Xcorporeal (Xcorporeal) Days Sales Outstanding : 0.00 (As of Sep. 2009)

View and export this data going back to . Start your Free Trial

What is Xcorporeal Days Sales Outstanding?

Xcorporeal's average Accounts Receivable for the three months ended in Sep. 2009 was $0.00 Mil. Xcorporeal's Revenue for the three months ended in Sep. 2009 was $0.00 Mil.

The historical rank and industry rank for Xcorporeal's Days Sales Outstanding or its related term are showing as below:

XCRP's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 65.015
* Ranked among companies with meaningful Days Sales Outstanding only.

Xcorporeal's Days Sales Outstanding stayed the same from Sep. 2008 (0.00) to Sep. 2009 (0.00).

Xcorporeal Days Sales Outstanding Historical Data

The historical data trend for Xcorporeal's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcorporeal Days Sales Outstanding Chart

Xcorporeal Annual Data

Trend

Feb99

Feb00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Days Sales Outstanding

Get a 7-Day Free Trial

Xcorporeal Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Xcorporeal's Days Sales Outstanding

For the Medical Devices subindustry, Xcorporeal's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xcorporeal's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Xcorporeal's Days Sales Outstanding falls into.

Xcorporeal Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Xcorporeal's Days Sales Outstanding for the fiscal year that ended in Dec. 2008 is calculated as

	Days Sales Outstanding (A: Dec. 2008 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2007 )	+	Accounts Receivable (A: Dec. 2008 ))	/	count )	/	Revenue (A: Dec. 2008 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Xcorporeal's Days Sales Outstanding for the quarter that ended in Sep. 2009 is calculated as:

	Days Sales Outstanding (Q: Sep. 2009 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2009 )	+	Accounts Receivable (A: Sep. 2009 ))	/	count )	/	Revenue (A: Sep. 2009 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Xcorporeal (GREY:XCRP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Xcorporeal Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Xcorporeal's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Xcorporeal (Xcorporeal) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xcorporeal Inc (GREY:XCRP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Empire Drive, Lake Forest, CA, USA, 92630

Website

Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.

Executives

Kelly J. Mccrann	director, officer: Chairman and CEO	11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025
Daniel S Goldberger	officer: Chief Executive Officer	24 CARPENTER ROAD, CHESTER NY 10918
Marc G Cummins	director	C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Prime Logic Capital, Llc	10 percent owner	135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Robert Weinstein	officer: Chief Financial Officer	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Terren S Peizer	director, 10 percent owner, officer: Executive Chairman	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Jay Wolf	director	981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049
Herve De Kergrohen	director	22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245
Nicholas Sheridan Lewin	director	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Lawrence Lacerte	10 percent owner	C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122